Anemia News, Research Articles | Anemia Treatment Studies



Study: Targeting Higher Hemoglobin May Improve Fatigue in CKD

For patients with chronic kidney disease (CKD) receiving erythropoiesis-stimulating agents (ESAs), achieving hemoglobin (Hb) levels higher than guideline-recommended target range is associated with a small but potentially clinically significant improvement in fatigue, although not in the ability to perform usual daily work or other activities. In a systematic review and meta-analysis of 15 randomized trials…

No Ophthalmic Effects From Roxadustat Short Term

In a study of patients on dialysis, investigators found no higher risk for retinal hemorrhages and other ophthalmic problems among roxadustat-treated patients compared with patients receiving darbepoetin alfa.
Next post in Anemia